Uncover key drivers, emerging technologies, and competitive movements shaping the connected drug delivery devices market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Connected Drug Delivery Devices Market be in 2030 compared with 2026?
The connected drug delivery devices market size has undergone substantial expansion in recent years. It is anticipated to grow from $9.27 billion in 2025 to $11.48 billion in 2026, at a compound annual growth rate (CAGR) of 23.8%. The historical period’s growth can be attributed to the growing adoption of chronic disease management devices, the increasing prevalence of diabetes and respiratory disorders, technological advancements in smart syringes and inhalers, rising healthcare digitization initiatives, and increasing awareness about medication adherence.
The connected drug delivery devices market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $27.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.9%. Factors contributing to this growth during the forecast period include an increasing need for remote patient observation, the broadening of connected healthcare environments, the incorporation of AI-based predictive analysis, the proliferation of wearable drug delivery technologies, and favorable government programs promoting digital health uptake. Key trends identified for the forecast period encompass tailored medication adherence tracking, solutions for remote patient oversight, seamless integration with electronic health records (EHR), dose optimization driven by data, and instantaneous alerts and notifications.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
What Drivers Are Guiding Growth Patterns In The Connected Drug Delivery Devices Market?
The growing significance of remote patient monitoring is projected to fuel the expansion of the connected drug delivery device market in the future. This healthcare delivery method involves utilizing technology to remotely observe and collect patient health and medical information. Connected drug delivery devices boost the effectiveness of RPM by allowing precise monitoring of how medications are used and followed, aiding in prompt actions, and delivering tailored care plans. As an example, the Canada-based peer-reviewed Journal of Medical Internet Research indicated in May 2024 that 38.78% of adults in the US had engaged with telehealth services over the preceding year. Consequently, the heightened emphasis on remote patient monitoring is propelling the growth of the connected drug delivery device market.
How Is The Connected Drug Delivery Devices Market Divided Into Segments?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
What Trends Are Reshaping The Dynamics Of The Connected Drug Delivery Devices Market?
Leading companies in the connected drug delivery devices market are concentrating on launching advanced, longer-lasting, and more integrated digital health solutions designed to enhance treatment convenience, improve monitoring accuracy, and support seamless connectivity with automated therapy systems. For instance, in November 2025, Dexcom, a US-based healthcare company, is set to launch its new G7 15 Day continuous glucose monitor in the U.S. on December 1, 2025, specifically for adults with diabetes. This device, having recently secured FDA clearance, will be the longest-wearing CGM available, offering usage for up to 15.5 days along with an improved accuracy MARD of 8%. At its release, it will be obtainable through DME providers and will be covered for Medicare users. The updated sensor is compatible with the iLet Bionic Pancreas, Omnipod 5, and will soon integrate with Tandem pumps, additionally supporting Dexcom’s new Smart Basal insulin optimization system. With fewer sensor changes, a waterproof design, smartwatch connectivity, and simplified logging features, the G7 15 Day aims to provide increased convenience and better long-term glucose management.
Which Key Players Are Driving Competition In The Connected Drug Delivery Devices Market?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
Access The Complete Report For Deeper Market Insights:
Which Region Is Projected To Lead The Connected Drug Delivery Devices Market During The Forecast Period?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Connected Drug Delivery Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp
Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2026, By The Business Research Company
Connected Drug Delivery Devices Market Report 2026
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model